Galapagos | Nettoeinkommen



Net Income Veränderung Datum
argenx SE USD 774.16M 682.75M 2024-12
AstraZeneca USD 1.5B 71M 2024-12
Biogen USD 266.7M 121.8M 2024-12
Genmab DKK 3.84B 2.58B 2024-12
Gilead Sciences USD 1.78B 529M 2024-12
GlaxoSmithKline GBP 414M 472M 2024-12
GRIFOLS EUR 68.97M 17.28M 2024-12
Hikma Pharmaceutical USD 226M 167M 2024-06
Incyte USD 201.21M 94.76M 2024-12
Merck EUR 667M 142M 2024-12
Neurocrine Biosciences USD 103.1M 26.7M 2024-12
Novartis USD 2.82B 371M 2024-12
Roche Holding CHF 1.01B 2.12B 2024-12
Sanofi EUR 2.82B 1.7B 2024-09
UCB EUR 104M 72M 2024-06
Vertex Pharmaceuticals USD 913M 132.4M 2024-12



Galapagos Nettoeinkommen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.